ArticleCurrent health sciences journal

Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.

Mădălina-Casiana Palfi Salavat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.